Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer

Published:2009-09-15 Issue:8 Volume:101 Page:1248-1252
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Mellado B,Font A,Alcaraz A,Aparicio L A,Veiga F J G,Areal J,Gallardo E,Hannaoui N,Lorenzo J R M,Sousa A,Fernandez P L,Gascon P

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6605320.pdf

Reference30 articles.

1. Berthold DR, Pond GR, Soban F, de Wit R, Eisenberger M, Tannock IF (2008) Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study. J Clin Oncol 26: 242–245

2. Bubley GJ, Carducci M, Dahut W, Dawson N, Daliani D, Eisenberger M, Figg WD, Freidlin B, Halabi S, Hudes G, Hussain M, Kaplan R, Myers C, Oh W, Petrylak DP, Reed E, Roth B, Sartor O, Scher H, Simons J, Sinibaldi V, Small EJ, Smith MR, Trump DL, Vollmer R, Wilding G (1999) Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol 17: 3461–3467

3. Burkhard FC, Studer UE (2008) The role of lymphadenectomy in high risk prostate cancer. World J Urol 26: 231–236

4. Chi KN, Chin JL, Winquist E, Klotz L, Saad F, Gleave ME (2008) Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer. J Urol 180: 565–570

5. D'Amico A (2007) Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective – identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy. BJU Int 99: S13–S16

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. When after radical prostatectomy radiotherapy should be performed? Comparison of adjuvant and salvage radiotherapy (literature review);Cancer Urology;2024-02-27

2. Efficacy of Neoadjuvant Chemohormonal Therapy in Oligometastatic Hormone-Sensitive Prostate Cancer: A Prospective, Three-Arm, Comparative Propensity Score Match Analysis;Clinical Genitourinary Cancer;2021-08

3. Neoadjuvant Chemohormonal Therapy before Radical Prostatectomy for Japanese Patients with High-Risk Localized Prostate Cancer;Medical Sciences;2021-04-09

4. Neoadjuvant Strategies Before Radical Prostatectomy for High Risk Prostate Cancer in the Era of New Hormonal Agents;Current Drug Targets;2020-12-31

5. Oncological results of neoadjuvant chemohormonal therapy in patients with high and very high-risk prostate cancer;Cancer Urology;2020-04-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3